Profound Medical Corp.
PROF
$4.78
$0.061.27%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -27.82M | -31.15M | -27.35M | -27.78M | -28.32M |
| Total Depreciation and Amortization | 936.00K | 806.00K | 870.00K | 905.00K | 929.00K |
| Total Amortization of Deferred Charges | 0.00 | 136.00K | 91.00K | 46.00K | -- |
| Total Other Non-Cash Items | 1.89M | 3.52M | 3.69M | 4.02M | 4.43M |
| Change in Net Operating Assets | 1.54M | 1.55M | -425.00K | 931.00K | 353.00K |
| Cash from Operations | -23.45M | -25.14M | -23.12M | -21.88M | -22.61M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -2.56M | -2.24M | -1.77M | -1.33M | -912.00K |
| Issuance of Common Stock | 62.15M | 22.94M | 22.95M | 23.18M | 2.67M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -4.90M | -1.86M | -1.86M | -1.86M | -- |
| Cash from Financing | 54.70M | 18.84M | 19.32M | 20.00M | 1.76M |
| Foreign Exchange rate Adjustments | -2.54M | -206.00K | -1.40M | 85.00K | 549.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 28.70M | -6.50M | -5.20M | -1.80M | -20.30M |